Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Helicobacter Pylori Eradication for the Treatment of Chronic or Persistent Immune Thrombocytopenic Purpura Patients With Moderate Thrombocytopenia: Multicenter Prospective Randomized Phase 3 Study

NCT03177629 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03177629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03177629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Helicobacter Pylori Eradication for the Treatment of Chronic or Persistent Immune Thrombocytopenic Purpura Patients With Moderate Thrombocytopenia: Multicenter Prospective Randomized Phase 3 Study
Lead sponsor
Seoul National University Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
May 23, 2017
Completion date
December 31, 2020
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori, immune thrombocytopenia, immune thrombocytopenic purpura